Terns Pharmaceuticals to Participate in Upcoming November Investor Conferences
FOSTER CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage ...
Washington coast avian flu outbreak devastated Caspian terns, jumped to seals
An epidemiological study found that 56% of a large breeding colony of Caspian terns died from a 2023 outbreak of highly ...
Deadly H5N1 Outbreak Triggers Unprecedented Caspian Tern Die-Off in Washington and Spreads ...
A 2023 avian flu outbreak decimated a Caspian tern colony on Rat Island and spread to harbor seals, posing a new threat to local wildlife. A 2023 epidemiological study revealed that 56% of a large ...
Fintel on MSN11 天
Oppenheimer Initiates Coverage of Terns Pharmaceuticals (TERN) with Outperform Recommendation
Fintel reports that on October 31, 2024, Oppenheimer initiated coverage of Terns Pharmaceuticals (NasdaqGS:TERN) with a ...
Seeking Alpha20 天
Terns Pharmaceuticals: Another Potential GLP-1 Entrant
Shares of biotech concern Terns Pharmaceuticals, Inc. (NASDAQ:TERN) are up somewhat higher since we first examined it in September of 2022, riding optimism concerning two early-stage clinical ...
Optimistic Outlook for Terns Pharmaceuticals: Potential of TERN-701 Amidst Market Opportunities
Mizuho Securities analyst Graig Suvannavejh has maintained their bullish stance on TERN stock, giving a Buy rating yesterday. Graig ...
Elephant Seal Colony Declines One Year After Avian Flu Outbreak
A year after an outbreak of H5N1 killed thousands of elephant seals, only about a third of the seals normally expected here ...
Terns Pharmaceuticals initiated with an Outperform at Oppenheimer
Oppenheimer initiated coverage of Terns Pharmaceuticals (TERN) with an Outperform rating and $82 price target Published first on TheFly ...
StringersHub on MSN8 小时
US: UNOSSC director calls for enhanced cooperation to address sustainable development shortfall
New York, United States - 09, 2024 The director of the United Nations Office for South-South Cooperation (UNOSSC) has ...
Oppenheimer 给予 Terns Pharmaceuticals 股票"跑赢大盘"评级，预计上涨空间150%
周四，Oppenheimer 对 Terns Pharmaceuticals (NASDAQ: TERN) 股票启动覆盖，给予"跑赢大盘"评级，并设定目标价为17.00美元。该公司分析师对公司的临床管线表示信心，特别强调了两个主要资产：用于慢性髓性白血病(CML)的TERN-701和用于肥胖症的TERN-601。 分析师指出，TERN-701是一种酪氨酸激酶抑制剂(TKI)，在剂量和耐受性方面可能 ...